SCHEMBL6364613

SCHEMBL6364613

COC1=CC(O)(OC)C(CC=C(C)C)=C(O)C1/C=C/C(=O)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.35
PTPN1 P18031 2/20 0.35
ABCB1 P08183 1/20 0.34
BCHE P06276 3/20 0.33
MAPT P10636 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
CYP3A4 P08684 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
LMNA P02545 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
PPARG P37231 1/20 0.31
PPARD Q03181 1/20 0.31
PPARA Q07869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6364833 0.74 MAPT (0.44) AKT1BCHEMAPTNPC1RAB9A
SCHEMBL3503674 0.64 MAPT (0.43) AKT1BCHEMAPTNPC1RAB9A
SCHEMBL372312 0.62 MAPT (0.40) AKT1BCHEMAPTNPC1RAB9A
SCHEMBL27641444 0.62 NPC1 (0.37) AKT1BCHEMAPTNPC1RAB9A
SCHEMBL1938587 0.61 NPC1 (0.41) AKT1BCHEMAPTNPC1RAB9A
SCHEMBL7803224 0.61 AKT1 (0.38) AKT1PTPN1BCHEMAPTNPC1
SCHEMBL27762382 0.60 NPC1 (0.40) AKT1BCHEMAPTNPC1RAB9A
SCHEMBL31345875 0.60 PPARG (0.63) PTPN1ABCB1MAPTLMNAPPARG
SCHEMBL28776174 0.60 NPC1 (0.39) AKT1BCHEMAPTNPC1RAB9A
SCHEMBL27883539 0.60 AKT1 (0.39) AKT1BCHEMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050031572-A1 Cosmetic or dermatological preparations including hops or hop-malt extracts and methods of using same for the prophylaxis and treatment of skin symptoms BEIERSDORF AG 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050031572-A1 Cosmetic or dermatological preparations including hops or hop-malt extracts and methods of using same for the prophylaxis and treatment of skin symptoms CUTA, TYR, HMBS AKT1 3043/4885PTPN1 279/4885ABCB1 2438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.